Erectile Dysfunction

Erectile dysfunction (ED) is the inability to achieve an erection or maintain it long enough for sexual intercourse. Some treatments for prostate cancer can cause ED:

Radical prostatectomy, a surgery that removes the prostate gland, the seminal vesicles and part of the urethra, is the most common cause of erectile dysfunction. The severity depends on the procedure's impact on the arteries and nerves that control erections. Most men who receive "nerve-sparing" surgery experience improvement over time (recovery may take a couple of years). Some men never recover the ability to have a spontaneous erection.

Radiation or brachytherapy can damage nerves and blood vessels, causing ED. Many men can achieve an erection with prescription medication.

Hormone treatments lower testosterone levels, which can cause ED and lower libido. Men with prostate cancer should not receive testosterone therapy, since this can encourage the growth of cancerous cells. Ask your doctor about treatment options.



Listen to this Expert Angle webinar with Dr. Radomski for more information:
 

Incontinence and Erectile Dysfunction with Dr. Sidney Radomski

May 19, 2015

This webinar explains what is urinary incontinence and erectile dysfunction. In addition to outlining the possible causes, diagnosis tests and treatment options for urinary incontinence and erectile dysfunction after prostate cancer treatment.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive